The impact of peri-procedural imaging on safety and efficacy of atrial fibrillation ablation: insights from the Israeli AF Catheter Ablation Registry (ICAR)

被引:0
|
作者
Marai, Ibrahim [1 ]
Elias, Adi [2 ,3 ]
Rozen, Guy [1 ]
Beinart, Roy [4 ,5 ]
Nof, Eyal [4 ,5 ]
Michowitz, Yoav [6 ,7 ]
Glikson, Michael [6 ,7 ]
Konstantino, Yuval [8 ]
Haim, Moti [8 ]
Luria, David [9 ,10 ]
Omelchenko, Alexander [5 ,11 ]
Laish-Farkash, Avishag [12 ]
Suleiman, Mahmoud [2 ,3 ]
机构
[1] PoriyaBar Ilan Univ, Azrieli Fac Med,Cardiovasc Dept, Lydia & Carol Kittner Poriya Med Ctr, Lea & Benjamin Davidai Div Cardiovasc Med & Surg, Lower Galilee, Tiberias, Israel
[2] Eyal Ofer Heart Hosp, Technion, Cardiac Electrophysiol & Pacing, Rambam Hlth Care Campus, Haifa, Israel
[3] Eyal Ofer Heart Hosp, Technion, B Rappaport Fac Med, Cardiac Electrophysiol & Pacing, Haifa, Israel
[4] Sheba Med Ctr, Heart Inst, Tel Hashomer, Israel
[5] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[6] Shaare Zedek Med Ctr, Jesselson Integrated Heart Ctr, Jerusalem, Israel
[7] Hebrew Univ Jerusalem, Jerusalem, Israel
[8] Ben Gurion Univ Negev, Soroka Univ Hosp, Dept Cardiol Cardiac Electrophysiol & Pacing, Beer Sheva, Israel
[9] Hebrew Univ Jerusalem, Dept Cardiol, Hadassah Med Org, Jerusalem, Israel
[10] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
[11] Meir Med Ctr, Cardiol Dept, Kefar Sava, Israel
[12] Ben Gurion Univ Negev, Assuta Ashdod Univ Med Ctr, Dept Cardiol Electrophysiol, Pacing Unit, Beer Sheva, Israel
关键词
Atrial fibrillation; Ablation; Imaging; Pulmonary vein isolation; RADIOFREQUENCY; OUTCOMES;
D O I
10.1007/s10840-024-01887-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPulmonary vein isolation (PVI) is the most effective therapy to achieve rhythm control in atrial fibrillation (AF). Peri-procedural imaging is used in many but not all centers. However, the impact of imaging on safety and efficacy of PVI is not clear. The Israeli Catheter Ablation Registry (ICAR) is a great opportunity to explore this issue in real-world practice.AimTo describe the real-world utilization of peri-procedural imaging technologies in a large cohort of patients undergoing ablation for AF.MethodsA prospective-multicenter cohort of AF patients who underwent PVI during the years 2019-2021. Peri-procedural imaging (CT, ICE, TEE) was utilized based on the center and operator discretion. The study endpoints were peri-procedural complications and AF recurrence at 12 months follow-up among patients with and without peri-procedural imaging.ResultsBetween January 2019 and December 2021, a total of 921 patients underwent PVI. Peri-procedural imaging (at least 1 modality of CT, TEE, and or ICE) was utilized in 753 (81.8%) and no imaging among 168 (18.2%) patients. Cryoablation was the dominant energy used for PVI in both groups (92.3% of the non-imaging group, and 95.3% among imaging group), while RF was used in the rest of the patients. Fluoroscopy time was not different between the 2 groups; however, procedure duration was longer among the imaging group (90 min) compared to the non-imaging group (74.5 min, p = 0.006). By 12 months, the incidence of AF recurrence and repeated ablation were not different between the groups. Complications and re-hospitalization for cardiocerebrovascular reasons were not different among the 2 groups. Cox regression model demonstrated no association between preprocedural imaging and the risk of AF recurrence after ablation.ConclusionThis real-world multicenter prospective registry study demonstrated that the rate of complications and the rate of recurrence of AF during 1 year follow-up were not different among patients who had PVI either with or without peri-procedural imaging.
引用
收藏
页码:73 / 81
页数:9
相关论文
共 50 条
  • [1] Peri-procedural Anticoagulation in Catheter Ablation Atrial Fibrillation: A Review
    Vrachatis, Dimitrios A.
    Giannopoulos, Georgios
    Kossyvakis, Charalambos
    Panagopoulou, Vasiliki
    Vavuranakis, Manolis
    Papaioannou, Theodore G.
    Pagoni, Stamatina
    Pyrgakis, Vlasios N.
    Cleman, Michael W.
    Deftereos, Spyridon G.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (09) : 1334 - 1345
  • [2] Safety and Efficacy of Catheter Ablation of Atrial Fibrillation in Octogenarians: Insights from the UC San Diego AF Ablation Registry
    Aldaas, Omar M.
    Darden, Douglas J.
    Mylavarapu, Praneet
    Han, Frederick
    Hoffmayer, Kurt S.
    Krummen, David E.
    Ho, Gordon
    Raissi, Farshad
    Feld, Gregory K.
    Hsu, Jonathan C.
    CIRCULATION, 2021, 144
  • [3] Safety and efficacy of uninterrupted treatment with edoxaban or warfarin during the peri-procedural period of catheter ablation for atrial fibrillation
    Naito, Kazuya
    Nakano, Masataka
    Iwasa, Atsushi
    Maeno, Yoshio
    Shintani, Yoshiaki
    Yamakawa, Takeshi
    Miyashita, Kotaro
    Oyama, Keishiro
    Nakai, Daisuke
    Katagiri, Masaya
    Kido, Hideaki
    Masuda, Shinichiro
    Kohashi, Keiichi
    Kawamata, Tetsuya
    Tanimoto, Shuzou
    Masuda, Naoki
    Ogata, Nobuhiko
    Isshiki, Takaaki
    JOURNAL OF ARRHYTHMIA, 2020, 36 (04) : 634 - 641
  • [4] Procedural Trends in Catheter Ablation of Persistent Atrial Fibrillation: Insights From the Real-AF Registry
    Sharma, Esseim
    Varley, Allyson
    Osorio, Jose
    Thorne, Christopher
    Varosy, Paul
    Metzl, Mark
    Rajendra, Anil
    Oza, Saumil
    Morales, Gustavo
    Magnano, Anthony
    D'Souza, Benjamin
    Sackett, Matthew
    Sellers, Matthew
    Silva, Jose
    Silverstein, Joshua
    Ho, Jeffrey
    Hoskins, Michael
    Kuk, Richard
    Romero, Jorge
    Zei, Paul C.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2023, 16 (06): : 382 - 384
  • [5] Editorial to "Safety and Efficacy of Uninterrupted Treatment with Edoxaban or Warfarin During the Peri-Procedural Period of Catheter Ablation for Atrial Fibrillation"
    Fukaya, Hidehira
    JOURNAL OF ARRHYTHMIA, 2020, 36 (04) : 642 - 643
  • [6] Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay
    Kimitake Imamura
    Akihiro Yoshida
    Asumi Takei
    Koji Fukuzawa
    Kunihiko Kiuchi
    Kaoru Takami
    Mitsuru Takami
    Mitsuaki Itoh
    Ryudo Fujiwara
    Atsushi Suzuki
    Tomoyuki Nakanishi
    Soichiro Yamashita
    Akinori Matsumoto
    Ken-ichi Hirata
    Journal of Interventional Cardiac Electrophysiology, 2013, 37 : 223 - 231
  • [7] Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay
    Imamura, Kimitake
    Yoshida, Akihiro
    Takei, Asumi
    Fukuzawa, Koji
    Kiuchi, Kunihiko
    Takami, Kaoru
    Takami, Mitsuru
    Itoh, Mitsuaki
    Fujiwara, Ryudo
    Suzuki, Atsushi
    Nakanishi, Tomoyuki
    Yamashita, Soichiro
    Matsumoto, Akinori
    Hirata, Ken-ichi
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2013, 37 (03) : 223 - 231
  • [8] Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey
    Iliodromitis, Konstantinos
    Lenarczyk, Radoslaw
    Scherr, Daniel
    Conte, Giulio
    Farkowski, Michal M.
    Marin, Francisco
    Garcia-Seara, Javier
    Simovic, Stefan
    Potpara, Tatjana
    EUROPACE, 2023, 25 (02): : 667 - 675
  • [9] Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis
    Bin Abdulhak, Aref A.
    Khan, Abdur Rahman
    Tleyjeh, Imad M.
    Spertus, John A.
    Sanders, Susan U.
    Steigerwalt, Kristy E.
    Garbati, Musa A.
    Bahmaid, Reem A.
    Wimmer, Alan P.
    EUROPACE, 2013, 15 (10): : 1412 - 1420
  • [10] Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
    Vazquez, Sara R.
    Johnson, Stacy A.
    Rondina, Matthew T.
    THROMBOSIS RESEARCH, 2010, 126 (02) : E69 - E77